EWTX Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-02-07 | MOORE JOHN R | officer: General Counsel | 105,004 | M-Exempt | D | 17,993 | 1.93 | 34,726.00 |
2024-02-08 | MOORE JOHN R | officer: General Counsel | 101,191 | M-Exempt | D | 3,813 | 1.93 | 7,359.00 |
2024-02-09 | MOORE JOHN R | officer: General Counsel | 93,162 | M-Exempt | D | 8,029 | 1.93 | 15,496.00 |
2024-02-07 | MOORE JOHN R | officer: General Counsel | 17,993 | M-Exempt | A | 17,993 | 1.93 | 34,726.00 |
2024-02-09 | MOORE JOHN R | officer: General Counsel | 8,029 | M-Exempt | A | 8,029 | 1.93 | 15,496.00 |
2024-02-08 | MOORE JOHN R | officer: General Counsel | 3,813 | M-Exempt | A | 3,813 | 1.93 | 7,359.00 |
2024-02-09 | MOORE JOHN R | officer: General Counsel | 0 | S-Sale | D | 8,029 | 20.01 | 160,657.00 |
2024-02-07 | MOORE JOHN R | officer: General Counsel | 0 | S-Sale | D | 17,993 | 20.00 | 359,864.00 |
2024-02-08 | MOORE JOHN R | officer: General Counsel | 0 | S-Sale | D | 3,813 | 20.01 | 76,285.00 |
2024-02-07 | Derakhshan Behrad | officer: Chief Business Officer | 154,417 | M-Exempt | D | 600 | 1.93 | 1,158.00 |
2024-02-08 | Derakhshan Behrad | officer: Chief Business Officer | 149,817 | M-Exempt | D | 4,600 | 1.93 | 8,878.00 |
2024-02-09 | Derakhshan Behrad | officer: Chief Business Officer | 145,017 | M-Exempt | D | 4,800 | 1.93 | 9,264.00 |
2024-02-09 | Derakhshan Behrad | officer: Chief Business Officer | 11,820 | M-Exempt | A | 4,800 | 1.93 | 9,264.00 |
2024-02-08 | Derakhshan Behrad | officer: Chief Business Officer | 11,620 | M-Exempt | A | 4,600 | 1.93 | 8,878.00 |
2024-02-07 | Derakhshan Behrad | officer: Chief Business Officer | 7,620 | M-Exempt | A | 600 | 1.93 | 1,158.00 |
2024-02-07 | Derakhshan Behrad | officer: Chief Business Officer | 7,020 | S-Sale | D | 600 | 20.00 | 12,000.00 |
2024-02-09 | Derakhshan Behrad | officer: Chief Business Officer | 7,020 | S-Sale | D | 4,800 | 20.04 | 96,209.00 |
2024-02-08 | Derakhshan Behrad | officer: Chief Business Officer | 7,020 | S-Sale | D | 4,600 | 20.01 | 92,049.00 |
2024-01-23 | Carruthers R Michael | officer: Chief Financial Officer | 137,058 | M-Exempt | D | 90,000 | 1.93 | 173,700.00 |
2024-01-23 | Carruthers R Michael | officer: Chief Financial Officer | 119,024 | M-Exempt | A | 90,000 | 1.93 | 173,700.00 |
2024-01-23 | Carruthers R Michael | officer: Chief Financial Officer | 29,024 | S-Sale | D | 90,000 | 15.78 | 1,419,759.00 |
2024-01-23 | Thompson Peter A. | director, 10 percent owner: | 14,436,497 | P-Purchase | A | 454,545 | 11.00 | 4,999,995.00 |
2024-01-23 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 14,436,497 | P-Purchase | A | 454,545 | 11.00 | 4,999,995.00 |
2023-12-26 | Fox Jonathan C | director | 10,857 | P-Purchase | A | 10,857 | 9.30 | 100,958.00 |
2023-12-27 | MOORE JOHN R | officer: General Counsel | 0 | S-Sale | D | 8,497 | 10.50 | 89,218.00 |
2023-12-26 | Russell Alan J | director, officer: Chief Scientific Officer | 3,606 | S-Sale | D | 172,585 | 9.33 | 1,610,097.00 |
2023-08-17 | Derakhshan Behrad | officer: Chief Business Officer | 220,000 | A-Award | A | 220,000 | 7.08 | 1,557,600.00 |
2023-08-17 | MOORE JOHN R | officer: General Counsel | 200,000 | A-Award | A | 200,000 | 7.08 | 1,416,000.00 |
2023-08-17 | Carruthers R Michael | officer: Chief Financial Officer | 200,000 | A-Award | A | 200,000 | 7.08 | 1,416,000.00 |
2023-08-17 | Russell Alan J | director, officer: Chief Scientific Officer | 200,000 | A-Award | A | 200,000 | 7.08 | 1,416,000.00 |
2023-08-17 | Semigran Marc | officer: Chief Development Officer | 133,333 | A-Award | A | 133,333 | 7.08 | 943,998.00 |
2023-08-17 | Donovan Joanne M. | officer: CMO | 200,000 | A-Award | A | 200,000 | 7.08 | 1,416,000.00 |
2023-08-17 | KOCH KEVIN | director, officer: President and CEO | 600,000 | A-Award | A | 600,000 | 7.08 | 4,248,000.00 |
2023-06-22 | Carruthers R Michael | officer: Chief Financial Officer | 197,122 | M-Exempt | D | 10,000 | 0.71 | 7,100.00 |
2023-06-22 | Carruthers R Michael | officer: Chief Financial Officer | 29,024 | M-Exempt | A | 10,000 | 0.71 | 7,100.00 |
2023-06-12 | Fox Jonathan C | director | 22,123 | A-Award | A | 22,123 | 9.55 | 211,275.00 |
2023-06-12 | Thompson Peter A. | director, 10 percent owner: | 22,123 | A-Award | A | 22,123 | 9.55 | 211,275.00 |
2023-06-12 | ROOT JONATHAN D | director | 22,123 | A-Award | A | 22,123 | 9.55 | 211,275.00 |
2023-06-12 | Edris Badreddin | director | 22,123 | A-Award | A | 22,123 | 9.55 | 211,275.00 |
2023-06-12 | Brege Laura | director | 22,123 | A-Award | A | 22,123 | 9.55 | 211,275.00 |
2023-05-01 | Derakhshan Behrad | officer: Chief Business Officer | 10,417 | M-Exempt | D | 5,208 | 0.00 | 0.00 |
2023-05-01 | Derakhshan Behrad | officer: Chief Business Officer | 8,767 | M-Exempt | A | 5,208 | 0.00 | 0.00 |
2023-05-02 | Derakhshan Behrad | officer: Chief Business Officer | 7,020 | S-Sale | D | 1,747 | 8.90 | 15,557.00 |
2023-05-01 | MOORE JOHN R | officer: General Counsel | 10,417 | M-Exempt | D | 5,208 | 0.00 | 0.00 |
2023-05-01 | MOORE JOHN R | officer: General Counsel | 8,462 | M-Exempt | A | 5,208 | 0.00 | 0.00 |
2023-05-02 | MOORE JOHN R | officer: General Counsel | 6,565 | S-Sale | D | 1,897 | 8.90 | 16,893.00 |
2023-05-01 | Carruthers R Michael | officer: Chief Financial Officer | 17,462 | M-Exempt | A | 5,208 | 0.00 | 0.00 |
2023-05-02 | Carruthers R Michael | officer: Chief Financial Officer | 16,126 | S-Sale | D | 1,336 | 8.90 | 11,897.00 |
2023-05-01 | Carruthers R Michael | officer: Chief Financial Officer | 10,417 | M-Exempt | D | 5,208 | 0.00 | 0.00 |
2023-05-01 | Russell Alan J | director, officer: Chief Scientific Officer | 177,793 | M-Exempt | A | 5,208 | 0.00 | 0.00 |
2023-05-02 | Russell Alan J | director, officer: Chief Scientific Officer | 176,191 | S-Sale | D | 1,602 | 8.90 | 14,266.00 |
2023-05-01 | Russell Alan J | director, officer: Chief Scientific Officer | 10,417 | M-Exempt | D | 5,208 | 0.00 | 0.00 |
2023-05-01 | Donovan Joanne M. | officer: CMO | 20,834 | M-Exempt | D | 10,416 | 0.00 | 0.00 |
2023-05-01 | Donovan Joanne M. | officer: CMO | 13,214 | M-Exempt | A | 10,416 | 0.00 | 0.00 |
2023-05-02 | Donovan Joanne M. | officer: CMO | 9,960 | S-Sale | D | 3,254 | 8.90 | 28,977.00 |
2023-05-01 | KOCH KEVIN | director, officer: President and CEO | 20,834 | M-Exempt | D | 10,416 | 0.00 | 0.00 |
2023-05-01 | KOCH KEVIN | director, officer: President and CEO | 10,416 | M-Exempt | A | 10,416 | 0.00 | 0.00 |
2023-05-02 | KOCH KEVIN | director, officer: President and CEO | 7,213 | S-Sale | D | 3,203 | 8.90 | 28,522.00 |
2023-03-03 | Fox Jonathan C | 43,731 | A-Award | A | 43,731 | 9.43 | 412,383.00 | |
2023-03-02 | Fox Jonathan C | 0 | 0 | 0.00 | 0.00 | |||
2022-12-30 | Semigran Marc | director: Chief Development Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
2022-12-19 | Semigran Marc | None | 0 | None | None | 0.00 | ||
2022-12-19 | Semigran Marc | 0 | 0 | 0.00 | 0.00 | |||
2022-10-03 | MOORE JOHN R | director: General Counsel | 122,997 | M-Exempt | D | 4,730 | 0.00 | 0.00 |
2022-10-03 | MOORE JOHN R | director: General Counsel | 7,730 | M-Exempt | A | 4,730 | 1.93 | 9,129.00 |
2022-10-03 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 4,730 | 9.76 | 46,155.00 |
2022-09-16 | Thompson Peter A. | director, 10 percent owner: | 13,981,952 | P-Purchase | A | 484,496 | 10.32 | 4,999,999.00 |
2022-09-16 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 13,981,952 | P-Purchase | A | 484,496 | 10.32 | 4,999,999.00 |
2022-09-14 | Novo Holdings A/S | 10 percent owner | 6,071,703 | P-Purchase | A | 484,496 | 10.32 | 4,999,999.00 |
2022-09-06 | MOORE JOHN R | director: General Counsel | 127,727 | M-Exempt | D | 4,730 | 0.00 | 0.00 |
2022-09-06 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 2,351 | 10.99 | 25,842.00 |
2022-08-08 | MOORE JOHN R | director: General Counsel | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
2022-08-08 | Russell Alan J | director: Chief Scientific Officer | 220,000 | A-Award | A | 220,000 | 0.00 | 0.00 |
2022-08-08 | Carruthers R Michael | director: Chief Financial Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
2022-08-08 | Derakhshan Behrad | director: Chief Business Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
2022-08-08 | Donovan Joanne M. | director: CMO | 240,000 | A-Award | A | 240,000 | 0.00 | 0.00 |
2022-08-08 | KOCH KEVIN | director: President and CEO | 550,000 | A-Award | A | 550,000 | 0.00 | 0.00 |
2022-08-03 | MOORE JOHN R | director: General Counsel | 112,558 | M-Exempt | D | 4,502 | 0.00 | 0.00 |
2022-08-03 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 9,232 | 9.31 | 85,921.00 |
2022-07-05 | MOORE JOHN R | director: General Counsel | 137,187 | M-Exempt | D | 1,046 | 0.00 | 0.00 |
2022-07-05 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 8,186 | 8.35 | 68,329.00 |
2022-06-24 | Thompson Peter A. | director, 10 percent owner: | 42,087 | A-Award | A | 42,087 | 8.53 | 359,002.00 |
2022-06-24 | Thompson Peter A. | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
2022-06-24 | ROOT JONATHAN D | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
2022-06-24 | ROOT JONATHAN D | director | 42,087 | A-Award | A | 42,087 | 8.53 | 359,002.00 |
2022-06-24 | Edris Badreddin | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
2022-06-24 | Edris Badreddin | director | 42,087 | A-Award | A | 42,087 | 8.53 | 359,002.00 |
2022-06-24 | Brege Laura | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
2022-06-24 | Brege Laura | director | 42,087 | A-Award | A | 42,087 | 8.53 | 359,002.00 |
2022-06-16 | MOORE JOHN R | director: General Counsel | 141,917 | M-Exempt | D | 17,570 | 0.00 | 0.00 |
2022-06-16 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 31,078 | 7.29 | 226,695.00 |
2022-06-13 | MOORE JOHN R | director: General Counsel | 196,336 | M-Exempt | D | 585 | 0.00 | 0.00 |
2022-06-13 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 18,075 | 6.11 | 110,445.00 |
2022-06-08 | MOORE JOHN R | director: General Counsel | 10,125 | M-Exempt | A | 7,125 | 0.71 | 5,059.00 |
2022-06-08 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 7,125 | 6.05 | 43,120.00 |
2022-06-03 | MOORE JOHN R | director: General Counsel | 197,894 | M-Exempt | D | 13,934 | 0.00 | 0.00 |
2022-06-03 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 17,150 | 6.61 | 113,276.00 |
2022-05-23 | Carruthers R Michael | director: Chief Financial Officer | 207,122 | M-Exempt | D | 9,000 | 0.71 | 6,390.00 |
2022-05-18 | OrbiMed Genesis GP LLC | director: | 13,497,456 | P-Purchase | A | 138,000 | 7.21 | 994,980.00 |
2022-05-18 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 13,497,456 | P-Purchase | A | 138,000 | 7.21 | 994,980.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.